According to Jazz Pharmaceuticals's latest financial reports the company's total assets are $11.39 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $11.39 B | 5.15% |
2022-12-31 | $10.83 B | -11.9% |
2021-12-31 | $12.29 B | 88.17% |
2020-12-31 | $6.53 B | 18% |
2019-12-31 | $5.53 B | 6.45% |
2018-12-31 | $5.20 B | 1.56% |
2017-12-31 | $5.12 B | 6.74% |
2016-12-31 | $4.80 B | 44.04% |
2015-12-31 | $3.33 B | -0.19% |
2014-12-31 | $3.33 B | 49.18% |
2013-12-31 | $2.23 B | 13.82% |
2012-12-31 | $1.96 B | 675.51% |
2011-12-31 | $0.25 B | 86.82% |
2010-12-31 | $0.13 B | 26.38% |
2009-12-31 | $0.10 B | -8.6% |
2008-12-31 | $0.11 B | -43.39% |
2007-12-31 | $0.20 B | -3.27% |
2006-12-31 | $0.21 B | 30.22% |
2005-12-31 | $0.16 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $99.94 B | 777.22% | ๐จ๐ญ Switzerland |
AmerisourceBergen
ABC | $61.17 B | 436.95% | ๐บ๐ธ USA |
Endo International
ENDPQ | $5.13 B | -54.91% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | $43.47 B | 281.62% | ๐ฎ๐ฑ Israel |